Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share (LYEL)
CUSIP: 55083R104
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock par value $0.0001 per share
- Shares outstanding
- 23,360,878
- Total 13F shares
- 128,413,620
- Share change
- -5,205,454
- Total reported value
- $176,562,559
- Put/Call ratio
- 1.1%
- Price per share
- $1.38
- Number of holders
- 115
- Value change
- -$7,293,208
- Number of buys
- 47
- Number of sells
- 50
Quarterly Holders Quick Answers
What is CUSIP 55083R104?
CUSIP 55083R104 identifies LYEL - Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 55083R104:
Top shareholders of LYEL - Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Robert Nelsen |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
36,542,716
mixed-class rows
|
$83,020,992 | — | 14 Jun 2024 | |
| GSK plc |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
30,253,189
|
$68,977,271 | — | 21 Jun 2021 | |
| MWG Management Ltd. |
13F
|
Company |
86%
|
20,162,332
|
$29,235,381 | — | 30 Jun 2024 | |
| Orland Properties Ltd |
13F
|
Company |
65%
|
15,093,969
|
$21,886,255 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
58%
|
13,495,132
|
$19,567,942 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
57%
|
13,398,298
|
$19,427,532 | — | 30 Jun 2024 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
36%
|
8,325,000
|
$12,071,250 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
34%
|
7,872,369
|
$11,416,000 | — | 30 Jun 2024 | |
| WuXi AppTec Co., Ltd. |
13F
|
Company |
33%
|
7,682,156
|
$11,139,126 | — | 30 Jun 2024 | |
| Hans Edgar Bishop |
3/4/5
|
Director |
—
mixed-class rows
|
4,815,614
mixed-class rows
|
$10,683,200 | — | 14 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
27%
|
6,405,098
|
$9,287,392 | — | 30 Jun 2024 | |
| Alphabet Inc. |
13F
|
Company |
25%
|
5,865,125
|
$8,504,431 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
17%
|
4,012,053
|
$5,818,669 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
16%
|
3,818,320
|
$5,536,564 | — | 30 Jun 2024 | |
| HSG Holding Ltd |
13F
|
Company |
13%
|
3,045,997
|
$4,995,435 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
12%
|
2,733,462
|
$3,963,520 | — | 30 Jun 2024 | |
| MIC Capital Management UK LLP |
13F
|
Company |
7.5%
|
1,740,569
|
$2,523,825 | — | 30 Jun 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
7.1%
|
1,670,000
|
$2,421,500 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
5.9%
|
1,389,041
|
$2,014,109 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
5.6%
|
1,297,642
|
$1,881,581 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
4.3%
|
1,004,642
|
$1,456,731 | — | 30 Jun 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
4.2%
|
985,336
|
$1,428,737 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
3.6%
|
843,257
|
$1,222,722 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.5%
|
809,560
|
$1,173,862 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
2.9%
|
671,966
|
$974,350 | — | 30 Jun 2024 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
2.5%
|
588,235
|
$852,941 | — | 30 Jun 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
2.5%
|
577,319
|
$837,113 | — | 30 Jun 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
2.4%
|
553,163
|
$802,086 | — | 30 Jun 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
2.3%
|
526,066
|
$762,796 | — | 30 Jun 2024 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
2.2%
|
519,998
|
$753,998 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
450,760
|
$653,603 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.7%
|
406,865
|
$589,955 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.7%
|
400,853
|
$581,237 | — | 30 Jun 2024 | |
| Clarius Group, LLC |
13F
|
Company |
1.7%
|
399,168
|
$578,794 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.7%
|
398,182
|
$577,364 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.6%
|
367,677
|
$533,132 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.5%
|
349,017
|
$506,075 | — | 30 Jun 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
1.3%
|
312,406
|
$452,989 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.2%
|
279,425
|
$405,166 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
275,721
|
$399,795 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
1.1%
|
260,742
|
$378,065 | — | 30 Jun 2024 | |
| Swiss National Bank |
13F
|
Company |
1.1%
|
247,400
|
$358,730 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.95%
|
220,790
|
$320,146 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.82%
|
192,609
|
$279,283 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.75%
|
175,800
|
$254,910 | — | 30 Jun 2024 | |
| BBR PARTNERS, LLC |
13F
|
Company |
0.7%
|
164,041
|
$237,859 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.65%
|
152,300
|
$220,835 | — | 30 Jun 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.62%
|
144,957
|
$210,188 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.61%
|
143,300
|
$207,785 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.61%
|
142,868
|
$207,158 | — | 30 Jun 2024 |
Institutional Holders of Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share (LYEL) as of Q3 2024
As of 30 Sep 2024,
Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share (LYEL) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
128,413,620 shares.
The largest 10 holders included
MWG Management Ltd., Orland Properties Ltd, BlackRock, Inc., VANGUARD GROUP INC, Foresite Capital Management IV, LLC, WuXi AppTec Co., Ltd., PRICE T ROWE ASSOCIATES INC /MD/, ORBIMED ADVISORS LLC, Alphabet Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
115
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
114
Q3 2024 holders
115
Holder diff
1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.